EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation of a method for measuring the antielastolytic activity of human circulating alpha1-antitrypsin

Magali Dechomet, Farid Zerimech, Colette Chapuis-Cellier, Christine Lombard, Malika Balduyck

Annales de Biologie Clinique · 2024

DOI: 10.1684/abc.2024.1893 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annales de Biologie Clinique, 2024. Verfasst von Magali Dechomet und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Immunologie biologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon et Université Claude Bernard-Lyon 1, Lyon, France. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin, alpha 1-Antitrypsin Deficiency, Pancreatic Elastase.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The existence of alpha-1 antitrypsin variants with apparently unremarkable phenotypes and serum concentrations, contrasting with a clinical picture suggestive of a severe deficiency, led us to investigate whether in these cases there was a reduction or even suppression of the capacity of alpha-1 antitrypsin to inhibit elastase. To this end, in two different laboratories, we adapted and validated a method for measuring the functional activity of alpha-1 antitrypsin, based on spectrophotometric kinetic analysis of the inhibition by serum alpha-1 antitrypsin of the hydrolytic activity of porcine pancreatic elastase on a chromogenic substrate. This method has proved to be robust, reproducible and transferable and made possible to define, on the basis of an analysis of a hospital population, a functionality index with a confidence interval comprised between 0.87 and 1.2, allowing to identify subjects likely to have a functional deficiency of alpha-1 antitrypsin, whether this deficiency being of a genetic origin without any quantitative or phenotypic translation, or whether being acquired under the effect of external agents (cigarette smoke or viruses).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha 1-Antitrypsinalpha 1-Antitrypsin DeficiencyPancreatic ElastaseHumansReproducibility of ResultsFemaleMaleAnimalsAdultSwineMiddle AgedSpectrophotometry

Stichwörter der Autor:innen

alpha1-antitrypsin deficiencyelastase-inhibitory capacitymethod validation

Substanzen

alpha 1-AntitrypsinPancreatic Elastase

Autor:innen und Institutionen

  • Service d'Immunologie biologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon et Université Claude Bernard-Lyon 1, Lyon, France.
  • CHU Lille, Service de Biochimie Biologie Moléculaire, Institut Pasteur Lille, Univ. Lille, ULR 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.
  • CHU Lille, Service de Biochimie Biologie Moléculaire, Univ. Lille, Laboratoire de Biochimie Biologie moléculaire, ULR 7364 - RADEME - Maladies RAres du DÉveloppement embryonnaire et du Métabolisme, F-59000 Lille, France.

Zitieren

APA

Dechomet, M., Zerimech, F., Chapuis-Cellier, C., Lombard, C., & Balduyck, M. (2024). Validation of a method for measuring the antielastolytic activity of human circulating alpha1-antitrypsin. Annales de Biologie Clinique. https://doi.org/10.1684/abc.2024.1893

Vancouver

Dechomet M, Zerimech F, Chapuis-Cellier C, Lombard C, Balduyck M. Validation of a method for measuring the antielastolytic activity of human circulating alpha1-antitrypsin. Annales de Biologie Clinique. 2024. doi:10.1684/abc.2024.1893

BibTeX
@article{Dechomet2024,
  author = {Dechomet, Magali and Zerimech, Farid and Chapuis-Cellier, Colette and Lombard, Christine and Balduyck, Malika},
  title = {Validation of a method for measuring the antielastolytic activity of human circulating alpha1-antitrypsin},
  journal = {Annales de Biologie Clinique},
  year = {2024},
  doi = {10.1684/abc.2024.1893}
}
Kostenlos starten →